Skip to main content
Fig. 12 | BMC Complementary Medicine and Therapies

Fig. 12

From: Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma

Fig. 12

TGT regulates the expression of key target genes in osteosarcoma cells 143B and SAOS2. The concentration of TGT is 75 mg/mL. A JUN, (B) TYMS, (C) HSP90AA1, (D) HDAC1, (E) CDK1, (F) ESR1, (G) TOP1, (H) EGFR, (I) STAT3, (J) NR3C1, (K) VEGFA, (L) AR, (M) CREBBP, and (N) PTGS2. Data are presented as mean ± SD (n = 4).*P < 0.1, **P < 0.01, ***P < 0.001 and ****P < 0.0001 versus the Control group

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us